Literature DB >> 28583814

Prospectively validated preoperative prediction of weight and co-morbidity resolution in individual patients comparing five bariatric operations.

Gus J Slotman1.   

Abstract

BACKGROUND: No method preoperatively predicts the postoperative bariatric surgery outcomes in individual patients. Decisions for or against surgery and operation choice remain subjective. Only 1% of qualifying patients embrace bariatric surgery.
OBJECTIVE: To predict preoperatively and validate prospectively the weight and co-morbidity resolution in individual patients after open Roux-en-Y gastric bypass (RYGB) and laparoscopic Roux-en-Y gastric bypass (LRYGB), laparoscopic adjustable gastric band (LAGB), sleeve gastrectomy (SG), and biliopancreatic diversion/duodenal switch (BPD/DS).
SETTING: Surgical Review Corporation BOLD database, 2007-2010.
METHODS: A total of 166,601 patients who had undergone RYGB (n = 5389), LRYGB (n = 83,059), LAGB (n = 67,514), SG (n = 8966), or BPD/DS (n = 1673) were randomized into modeling (n = 124,053) and validation (n = 42,548) groups. From preoperative data, multivariate linear and logistic regression predicted weight and co-morbidities at 2, 6, 12, 18, and 24 months postoperatively. Model fit was examined by R2 and receiver operating characteristic/area under the curve and predicted versus observed results via Pearson correlation coefficient and sensitivity/specificity.
RESULTS: Follow-up at 2/24 months was 120,909/11,014 for the modeling group and 41,528/3703 for validation. Weight models' R2 was .910, .813, .725, .638, and .613 at 2, 6, 12, 18, and 24 months, respectively. The categorical receiver operating characteristic/area under the curve was .617 to .949 for 24-month predictions. Pearson continuous coefficients were .969 and .811 at 2 and 24 months, respectively. The median 24-month sensitivity and specificity of co-morbidity resolution were 79.2% and 97.42%, respectively.
CONCLUSIONS: Prospectively validated preoperative models predict, in individual patients, weight and obesity co-morbidities 2 years in advance for RYGB, LRYGB, LAGB, SG, and BPD/DS. This advance knowledge facilitates choosing the operation that is best for each individual and may encourage more patients to choose bariatric surgery.
Copyright © 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery results prediction; Outcomes; Prognostic models

Mesh:

Year:  2017        PMID: 28583814     DOI: 10.1016/j.soard.2017.04.013

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  2 in total

1.  Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy Treatments for Obesity: Systematic Review and Meta-Analysis of Short- and Mid-Term Results.

Authors:  Sergio Barrichello; Mauricio Kazuyoshi Minata; Amador García Ruiz de Gordejuela; Wanderley Marques Bernardo; Thiago Ferreira de Souza; Manoel Galvão Neto; Diogo Turiani Hourneaux de Moura; Marco Aurélio Santo; Eduardo Guimarães Hourneaux de Moura
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

2.  Check point to get adequate weight loss within 6-months after laparoscopic sleeve gastrectomy for morbid obesity in Asian population.

Authors:  Ming-Hsien Lee; Jian-Han Chen; Chung-Yen Chen; Cheng-Hung Lee; Hui-Ming Lee; Wen-Yao Yin; Wei-Leng Chin
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.